Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
Just nowEZLynx Receives Gold Stevie Award® in the 2026 American Business Awards®
Just nowGreentown Go Make 2026 with Shell and Technip Energies Announces Startup Cohort
Just now/R E P E A T -- BRP Will Present Its First Quarter Fiscal Year 2027 Results and Hold Its Annual Meeting of Shareholders/
Just nowArlo Technologies to Present at the William Blair Growth Stock Conference
1m agoHII to Participate in Bernstein’s 42nd Annual Strategic Decisions Conference on May 28
Kalvista Pharmaceuticals, Inc. logo

Kalvista Pharmaceuticals, Inc.

About

26.81USD+0.04 +0.15%
Closed • Updated at 13:38 GMT+00:00
Market Cap$1.43B
Volume5.54M
Beta0.44
RSI75.16
Health TechnologyPharmaceuticals: Major

Kalvista Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 29 2026
Chiesi Group to Acquire KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio
Apr 8 2026
KalVista Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
Mar 30 2026
KalVista Pharmaceuticals Announces Positive Interim Phase 3 Data From KONFIDENT-KID Trial of EKTERLY® (sebetralstat) for Children Aged 2-11 Years at the 2026 Global Angioedema Leadership Conference
Mar 25 2026
KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update
Mar 20 2026
KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the 2026 Global Angioedema Leadership Conference

Community Chat

Ask AI

6ix6ixAIEvents